00:13:34 EST Wed 28 Feb 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for C:MYCO from 2023-03-01 to 2024-02-28 - 40 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2024-02-22 16:15C:MYCOMydecine Innovations Group Inc (2)0.013News ReleaseMydecine closes $52,370 debt settlement
2024-02-07 17:11C:MYCOMydecine Innovations Group Inc (2)0.015News ReleaseMydecine receives MYCO-005, -006 notices of allowance
2024-02-05 03:03C:MYCOMydecine Innovations Group Inc (2)0.015News ReleaseMydecine to issue 2.61M shares for debt of $52,370
2024-02-02 16:11C:MYCOMydecine Innovations Group Inc (2)0.02News ReleaseMydecine's Stevenson-Moore resigns as director
2023-12-18 09:17C:MYCOMydecine Innovations Group Inc (2)0.105News ReleaseMydecine receives notice of allowance for MYCO-005
2023-11-28 16:35C:MYCOMydecine Innovations Group Inc (2)0.12News ReleaseMydecine clarifies statements on special access program
2023-11-16 02:05C:MYCOMydecine Innovations Group Inc (2)0.135SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-16 01:58C:MYCOMydecine Innovations Group Inc (2)0.135SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-10-31 11:45C:MYCOMydecine Innovations Group Inc (2)0.12News ReleaseMydecine files prospectus supplement; issues shares
2023-10-26 11:17C:MYCOMydecine Innovations Group Inc (2)0.145News ReleaseMydecine talks drug discovery work with API
2023-10-10 12:00C:MYCOMydecine Innovations Group Inc (2)0.175News ReleaseMydecine completes admission to AQSE
2023-10-05 17:17C:MYCOMydecine Innovations Group Inc (2)0.14News ReleaseMydecine Innovations to trade on CSE Oct. 6
2023-10-05 14:25C:MYCOMydecine Innovations Group Inc (2)0.135New ListingMydecine Innovations to trade on CSE Oct. 6
2023-10-04 19:38C:MYCOMydecine Innovations Group Inc (2)0.135MiscellaneousMydecine Innovations to be delisted from Neo
2023-09-27 17:30C:MYCOMydecine Innovations Group Inc (2)0.13News ReleaseMydecine Innovations to trade in U.K. starting Oct. 10
2023-09-19 16:12C:MYCOMydecine Innovations Group Inc (2)0.19News ReleaseMydecine closes $3.75M prospectus supplement offering
2023-09-15 17:41C:MYCOMydecine Innovations Group Inc (2)0.185News ReleaseMydecine files prospectus supplement for offering
2023-08-30 16:09C:MYCOMydecine Innovations Group Inc (2)0.195News ReleaseMydecine receives conditional approval to list on CSE
2023-08-15 02:34C:MYCOMydecine Innovations Group Inc (2)0.18News ReleaseMydecine has June 30 cash position of $40,458
2023-08-14 19:08C:MYCOMydecine Innovations Group Inc (2)0.18SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-07-21 17:42C:MYCOMydecine Innovations Group Inc (2)0.17News ReleaseMydecine director Heinzl resigns
2023-07-05 16:34C:MYCOMydecine Innovations Group Inc (2)0.22News ReleaseMydecine shareholders approve all matters at AGSM
2023-05-29 20:01C:MYCOMydecine Innovations Group Inc (2)0.31News ReleaseMydecine closes $500K 1st tranche; adds Heinzl director
2023-05-16 16:17C:MYCOMydecine Innovations Group Inc (2)0.34News ReleaseMydecine spends $143,334 on R&D in Q1
2023-05-15 19:31C:MYCOMydecine Innovations Group Inc (2)0.34SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-05-15 19:31C:MYCOMydecine Innovations Group Inc (2)0.34SEDAR MD & ASEDAR MD & A
2023-05-10 17:13C:MYCOMydecine Innovations Group Inc (2)0.37News ReleaseMydecine shareholders elect three directors at AGM
2023-04-24 11:34C:MYCOMydecine Innovations Group Inc (2)0.58News ReleaseMydecine releases MYCO-006 preclinical results
2023-04-20 20:38C:MYCOMydecine Innovations Group Inc (2)0.66Street WireBCSC imposes 20-year ban on Vancouver's Liem
2023-04-19 17:23C:MYCOMydecine Innovations Group Inc (2)News ReleaseMydecine Innovations completes $1-million financing
2023-04-10 20:37C:MYCOMydecine Innovations Group Inc (2)0.80MiscellaneousMydecine Innovations under Neo delisting review
2023-04-10 15:03C:MYCOMydecine Innovations Group Inc (2)0.81News ReleaseMydecine files shelf prospectus supplement
2023-04-03 11:52C:MYCOMydecine Innovations Group Inc (2)0.63News ReleaseMydecine Innovations to focus on CROs
2023-03-31 20:39C:MYCOMydecine Innovations Group Inc (2)0.63News ReleaseMydecine Innovations spends $3.58M on R&D in 2022
2023-03-31 20:33C:MYCOMydecine Innovations Group Inc (2)0.63SEDAR MD & ASEDAR MD & A
2023-03-31 20:32C:MYCOMydecine Innovations Group Inc (2)0.63SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2023-03-31 20:15C:MYCOMydecine Innovations Group Inc (2)0.63SEDAR Annual Information FormSEDAR Annual Information Form
2023-03-15 13:47C:MYCOMydecine Innovations Group Inc (2)0.485SEDAR MD & ASEDAR MD & A
2023-03-15 10:40C:MYCOMydecine Innovations Group Inc (2)0.485News ReleaseMydecine arranges subscription agreement for up to $10M
2023-03-06 13:49C:MYCOMydecine Innovations Group Inc (2)0.58News ReleaseMydecine to settle $752,160 of debt with shares